|
|
|
|
|
|
Dexcom (DXCM)
|
|
77.33 -1.35 (-1.72%)
|
6/23/2017 4:00pm
|
|
Open:
|
78.47
|
Pre. Close:
|
78.68
|
|
High:
|
79.05
|
Low:
|
77.27
|
|
Volume:
|
903,940
|
Market Cap:
|
6.68B
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
79.93 - 81.31
|
81.31 - 82.14
|
|
Low:
|
74.94 - 75.89
|
75.89 - 76.46
|
|
Close:
|
75.76 - 77.98
|
77.98 - 79.32
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-23 4:33:54 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 92.63 One year: 108.20
|
|
Support:
|
Support1: 71.18 Support2: 66.16
|
|
Resistance:
|
Resistance1:
79.31 Resistance2: 92.63
|
|
Pivot:
|
73.37 
|
|
Moving Averages:
|
MA(5): 78.03 MA(20): 72.09
MA(100): 76.48 MA(250): 78.09
|
|
MACD:
|
MACD(12,26):
1.74 Signal(12,26,9): 0.68
|
|
%K %D:
|
%K(14,3): 91.46 %D(3): 93.13
|
|
RSI:
|
RSI(14): 61.96
|
|
52-Week:
|
High: 96.38
Low: 57.68 Change(%): -0.3
|
|
Average Vol(K):
|
3-Month: 65261
10-Days 1086
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.DXCM has closed below upper band by 26.4%. Bollinger Bands are 80.9% wider than normal. The large width of the bands suggest high volatility as compared to DXCM's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
Tue, 30 May 2017 16:07:30 GMT
Dexcom's Implantable Blood Sugar Monitor Sales Rise
Fri, 23 Jun 2017 22:07:30 GMT
DexCom, Inc. (DXCM) Position Cut by Paulson & CO. Inc.
Fri, 23 Jun 2017 10:41:15 GMT
Healthcare Stock Performance Review -- Organovo, CR Bard, Bruker, and DexCom
Tue, 20 Jun 2017 12:22:30 GMT
Two stocks you should always put money on: DexCom, Inc. (DXCM), Knight ...
Fri, 23 Jun 2017 02:03:45 GMT
Pounding the Pavement on Shares of DexCom, Inc. (NasdaqGS:DXCM)
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
